Arkolith/Insider Trading/NKTR/Form 4

Robin Howard W

President & CEO, DirectorNEKTAR THERAPEUTICS (NKTR) · full profile →Form 4 · filed Dec 19, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$132K
Net Open-Market Flow
-$132K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2024Sell(S)85K$0.99$84K1.1M
Dec 17, 2024Sell(S)47K$1.01$47K1.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-138693) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML